• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

功能型纤溶酶原激活物抑制剂 1 在血小板激活后保留在活化的血小板膜上。

Functional plasminogen activator inhibitor 1 is retained on the activated platelet membrane following platelet activation.

机构信息

Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.

出版信息

Haematologica. 2020 Dec 1;105(12):2824-2833. doi: 10.3324/haematol.2019.230367.

DOI:10.3324/haematol.2019.230367
PMID:33256381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7716352/
Abstract

Platelets harbor the primary reservoir of circulating plasminogen activator inhibitor 1 (PAI-1), but the reportedly low functional activity of this pool of inhibitor has led to debate over its contribution to thrombus stability. Here we analyze the fate of PAI-1 secreted from activated platelets and examine its role in maintaining thrombus integrity. Activation of platelets results in translocation of PAI-1 to the outer leaflet of the membrane, with maximal exposure in response to strong dual agonist stimulation. PAI-1 is found to co-localize in the cap of PS-exposing platelets with its cofactor, vitronectin, and fibrinogen. Inclusion of tirofiban or Gly-Pro-Arg-Pro significantly attenuated exposure of PAI-1, indicating a crucial role for integrin αIIbβ3 and fibrin in delivery of PAI-1 to the activated membrane. Separation of platelets post-stimulation into soluble and cellular components revealed the presence of PAI-1 antigen and activity in both fractions, with approximately 40% of total platelet-derived PAI-1 remaining associated with the cellular fraction. Using a variety of fibrinolytic models we found that platelets produce a strong stabilizing effect against tPA-mediated clot lysis. Platelet lysate, as well as soluble and cellular fractions stabilize thrombi against premature degradation in a PAI-1 dependent manner. Our data show for the first time that a functional pool of PAI-1 is anchored to the membrane of stimulated platelets and regulates local fibrinolysis. We reveal a key role for integrin αIIbβ3 and fibrin in delivery of PAI-1 from platelet α-granules to the activated membrane. These data suggest that targeting platelet-associated PAI-1 may represent a viable target for novel profibrinolytic agents.

摘要

血小板是循环型纤溶酶原激活物抑制剂 1(PAI-1)的主要储存库,但据报道,该抑制剂池的功能活性较低,这导致了其对血栓稳定性的贡献存在争议。在这里,我们分析了从激活的血小板中分泌的 PAI-1 的命运,并研究了其在维持血栓完整性中的作用。血小板的激活导致 PAI-1 易位到膜的外叶,在强双重激动剂刺激下最大程度地暴露。发现 PAI-1 与它的辅因子,纤连蛋白和纤维蛋白原在暴露 PS 的血小板的帽中共同定位。包含替罗非班或 Gly-Pro-Arg-Pro 显著减弱了 PAI-1 的暴露,表明整合素 αIIbβ3 和纤维蛋白在将 PAI-1 递送到激活的膜中起着关键作用。刺激后将血小板分离成可溶性和细胞成分,揭示了两种成分中均存在 PAI-1 抗原和活性,大约 40%的总血小板衍生的 PAI-1 仍然与细胞成分相关。使用各种纤维蛋白溶解模型,我们发现血小板对 tPA 介导的血凝块溶解产生强烈的稳定作用。血小板裂解物以及可溶性和细胞成分以 PAI-1 依赖性方式稳定血栓,防止过早降解。我们的数据首次表明,功能型 PAI-1 池被锚定在受刺激的血小板的膜上,并调节局部纤维蛋白溶解。我们揭示了整合素 αIIbβ3 和纤维蛋白在将 PAI-1 从血小板 α-颗粒递送到激活的膜中的关键作用。这些数据表明,针对血小板相关的 PAI-1 可能是新型抗纤维蛋白溶解剂的可行靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe9f/7716352/9c1086cf169b/1052824.fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe9f/7716352/8ba52b160913/1052824.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe9f/7716352/678257edbe4b/1052824.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe9f/7716352/80d29fd04086/1052824.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe9f/7716352/1fbf39e0e9f0/1052824.fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe9f/7716352/296000d793dc/1052824.fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe9f/7716352/04f3120f8395/1052824.fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe9f/7716352/9c1086cf169b/1052824.fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe9f/7716352/8ba52b160913/1052824.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe9f/7716352/678257edbe4b/1052824.fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe9f/7716352/80d29fd04086/1052824.fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe9f/7716352/1fbf39e0e9f0/1052824.fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe9f/7716352/296000d793dc/1052824.fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe9f/7716352/04f3120f8395/1052824.fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe9f/7716352/9c1086cf169b/1052824.fig7.jpg

相似文献

1
Functional plasminogen activator inhibitor 1 is retained on the activated platelet membrane following platelet activation.功能型纤溶酶原激活物抑制剂 1 在血小板激活后保留在活化的血小板膜上。
Haematologica. 2020 Dec 1;105(12):2824-2833. doi: 10.3324/haematol.2019.230367.
2
Plasminogen activator inhibitor-1 released from activated platelets plays a key role in thrombolysis resistance. Studies with thrombi generated in the Chandler loop.从活化血小板释放的纤溶酶原激活物抑制剂-1在溶栓抵抗中起关键作用。对钱德勒环路中形成的血栓进行的研究。
Arterioscler Thromb. 1994 Sep;14(9):1452-8. doi: 10.1161/01.atv.14.9.1452.
3
Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus.血小板释放的纤溶酶原激活物抑制剂1对纤维蛋白溶解的调节作用:模型血小板 - 纤维蛋白血栓溶解的光散射和超微结构检查
Blood. 1993 Mar 1;81(5):1290-9.
4
Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow.纤溶酶原与暴露磷脂酰丝氨酸的血小板结合,并在血流状态下促进血栓溶解。
Blood. 2015 Apr 16;125(16):2568-78. doi: 10.1182/blood-2014-09-599480. Epub 2015 Feb 23.
5
Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms.血小板在体外通过纤溶酶原激活物抑制剂-1依赖和非依赖机制抑制纤维蛋白溶解。
Blood. 1994 Jan 15;83(2):351-6.
6
Platelets retain high levels of active plasminogen activator inhibitor 1.血小板中保持着高水平的活性纤溶酶原激活物抑制剂 1。
PLoS One. 2011;6(11):e26762. doi: 10.1371/journal.pone.0026762. Epub 2011 Nov 1.
7
Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.血小板释放1型纤溶酶原激活物抑制剂对溶栓作用的减弱。
Thromb Res. 1993 Dec 1;72(5):413-21. doi: 10.1016/0049-3848(93)90241-f.
8
The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.α2-抗纤溶酶和纤溶酶原激活物抑制剂1(PAI-1)在抑制血凝块溶解中的作用。
Thromb Haemost. 1993 Aug 2;70(2):301-6.
9
Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface.暴露于活化血小板和血小板微粒上的波形蛋白将玻连蛋白和纤溶酶原激活物抑制剂复合物定位在其表面。
J Biol Chem. 2002 Mar 1;277(9):7529-39. doi: 10.1074/jbc.M109675200. Epub 2001 Dec 14.
10
Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface.使纤维蛋白与整合素受体解偶联可加速血小板 - 纤维蛋白界面处的纤维蛋白溶解。
Blood. 1994 Feb 15;83(4):982-93.

引用本文的文献

1
Senolytic treatment with fisetin reverses age-related endothelial dysfunction partially mediated by SASP factor CXCL12.用漆黄素进行衰老细胞裂解疗法可逆转部分由衰老相关分泌表型因子CXCL12介导的与年龄相关的内皮功能障碍。
bioRxiv. 2025 Aug 18:2025.08.13.670216. doi: 10.1101/2025.08.13.670216.
2
Clot formation and resolution properties of platelets during cold storage for 21 days.血小板在冷藏21天期间的凝血和溶解特性。
Transfusion. 2025 Jul;65(7):1307-1318. doi: 10.1111/trf.18283. Epub 2025 May 16.
3
Fibrinolysis biomarker, thrombin, and activated protein C level alterations after coagulation activation depend on type of thrombophilia and clinical phenotype.
凝血激活后纤维蛋白溶解生物标志物、凝血酶和活化蛋白C水平的改变取决于血栓形成倾向的类型和临床表型。
Res Pract Thromb Haemost. 2024 Feb 15;8(2):102351. doi: 10.1016/j.rpth.2024.102351. eCollection 2024 Feb.
4
Thrombus composition and thrombolysis resistance in stroke.中风中的血栓成分与溶栓抵抗
Res Pract Thromb Haemost. 2023 May 16;7(4):100178. doi: 10.1016/j.rpth.2023.100178. eCollection 2023 May.
5
Identification of genomic loci regulating platelet plasminogen activator inhibitor-1 in mice.鉴定调控小鼠血小板纤溶酶原激活物抑制剂-1的基因组位点。
J Thromb Haemost. 2023 Oct;21(10):2917-2928. doi: 10.1016/j.jtha.2023.06.018. Epub 2023 Jun 25.
6
All tangled up: interactions of the fibrinolytic and innate immune systems.错综复杂:纤维蛋白溶解系统与先天免疫系统的相互作用。
Front Med (Lausanne). 2023 Jun 2;10:1212201. doi: 10.3389/fmed.2023.1212201. eCollection 2023.
7
"Super" SERPINs-A stabilizing force against fibrinolysis in thromboinflammatory conditions.“超级”丝氨酸蛋白酶抑制剂——血栓炎症状态下对抗纤维蛋白溶解的稳定力量。
Front Cardiovasc Med. 2023 Apr 19;10:1146833. doi: 10.3389/fcvm.2023.1146833. eCollection 2023.
8
Effects of the circulating environment of COVID-19 on platelet and neutrophil behavior.新型冠状病毒循环环境对血小板和中性粒细胞功能的影响。
Front Immunol. 2023 Mar 14;14:1130288. doi: 10.3389/fimmu.2023.1130288. eCollection 2023.
9
Location, location, location: Fibrin, cells, and fibrinolytic factors in thrombi.位置、位置、位置:血栓中的纤维蛋白、细胞及纤维蛋白溶解因子
Front Cardiovasc Med. 2023 Jan 18;9:1070502. doi: 10.3389/fcvm.2022.1070502. eCollection 2022.
10
Determinants of Endogenous Fibrinolysis in Whole Blood Under High Shear in Patients With Myocardial Infarction.心肌梗死患者全血在高剪切力下内源性纤维蛋白溶解的决定因素
JACC Basic Transl Sci. 2022 Aug 24;7(11):1069-1082. doi: 10.1016/j.jacbts.2022.05.007. eCollection 2022 Nov.